Literature DB >> 6223805

Platelet-derived growth factor selectively decreases prolactin production in pituitary cells in culture.

N J Sullivan, A H Tashjian.   

Abstract

Platelet-derived growth factor (PDGF) markedly reduced the production of PRL without affecting GH production in GH4C1 cells. The ED50 was 6 ng/ml (2 X 10(-10) M), and maximum inhibition occurred at 50 ng/ml (1.5 X 10(-9) M) PDGF. There was no acute effect of PDGF on PRL release. PDGF treatment decreased PRL production after a 24-h lag; suppression of the rate of PRL production became maximal between 24-48 h and persisted for at least 14 days in the continued presence of PDGF. There was no effect of PDGF on cell proliferation under the conditions used, and no effect on leucine uptake or incorporation into protein. PDGF altered the morphology of cells in a manner similar to that of epidermal growth factor and TRH, and caused the cells to become more adherent to the culture substrate. The actions of PDGF were similar in GH4C1 and GH3 cells, but in the non-PRL-producing GC cells, PDGF enhanced GH production. PDGF antagonized the PRL synthesis-stimulating activity of TRH. We conclude that PDGF can act directly on pituitary cells to decrease selectively the production of PRL.

Mesh:

Substances:

Year:  1983        PMID: 6223805     DOI: 10.1210/endo-113-2-639

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  3 in total

Review 1.  Genesis of prolactinomas: studies using estrogen-treated animals.

Authors:  Dipak K Sarkar
Journal:  Front Horm Res       Date:  2006       Impact factor: 2.606

2.  Cell-specific expression of the human parathyroid hormone gene in rat pituitary cells.

Authors:  T Igarashi; T Okazaki; H Potter; R Gaz; H M Kronenberg
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

3.  Imatinib Inhibits GH Secretion From Somatotropinomas.

Authors:  Prakamya Gupta; Ashutosh Rai; Kanchan Kumar Mukherjee; Naresh Sachdeva; Bishan Das Radotra; Raj Pal Singh Punia; Rakesh Kumar Vashista; Debasish Hota; Anand Srinivasan; Sivashanmugam Dhandapani; Sunil Kumar Gupta; Anil Bhansali; Pinaki Dutta
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-27       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.